Grantham, Mayo, Van Otterloo & Co (GMO)
BMY icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Bristol-Myers Squibb BMY Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.2M Sell
432,391
-546,497
-56% -$31.9M 0.07% 148
2025
Q4 		$52.8M Buy
978,888
+10,913
+1% +$525K 0.14% 63
2025
Q3 		$43.7M Buy
967,975
+97,671
+11% +$4.56M 0.12% 84
2025
Q2 		$40.3M Buy
870,304
+696,908
+402% +$34.2M 0.12% 91
2025
Q1 		$10.6M Buy
173,396
+152,376
+725% +$8.88M 0.03% 232
2024
Q4 		$1.19M Sell
21,020
-206,953
-91% -$11.6M ﹤0.01% 424
2024
Q3 		$11.8M Sell
227,973
-272,273
-54% -$12.8M 0.04% 253
2024
Q2 		$20.8M Sell
500,246
-28,723
-5% -$1.29M 0.07% 188
2024
Q1 		$28.7M Sell
528,969
-66,388
-11% -$3.38M 0.1% 143
2023
Q4 		$30.5M Sell
595,357
-47,727
-7% -$2.51M 0.13% 131
2023
Q3 		$37.3M Buy
643,084
+16,953
+3% +$1.04M 0.18% 104
2023
Q2 		$40M Buy
626,131
+129,122
+26% +$8.66M 0.19% 99
2023
Q1 		$34.4M Buy
497,009
+48,700
+11% +$3.43M 0.18% 115
2022
Q4 		$32.3M Buy
448,309
+201,622
+82% +$15.2M 0.17% 128
2022
Q3 		$17.5M Buy
246,687
+76,900
+45% +$5.58M 0.1% 195
2022
Q2 		$13.1M Sell
169,787
-121,609
-42% -$9.26M 0.07% 226
2022
Q1 		$21.3M Sell
291,396
-387,763
-57% -$26M 0.1% 178
2021
Q4 		$42.3M Buy
679,159
+436,675
+180% +$25.6M 0.2% 76
2021
Q3 		$14.3M Buy
242,484
+52,993
+28% +$3.49M 0.07% 208
2021
Q2 		$12.7M Buy
189,491
+43,100
+29% +$2.81M 0.06% 221
2021
Q1 		$9.24M Buy
146,391
+70,300
+92% +$4.37M 0.05% 244
2020
Q4 		$4.72M Sell
76,091
-1,200
-2% -$73.8K 0.03% 300
2020
Q3 		$4.66M Hold
77,291
– – 0.03% 247
2020
Q2 		$4.54M Sell
77,291
-83,406
-52% -$4.99M 0.03% 260
2020
Q1 		$8.96M Buy
160,697
+61,203
+62% +$3.74M 0.07% 150
2019
Q4 		$6.39M Sell
99,494
-16,672
-14% -$955K 0.04% 256
2019
Q3 		$5.89M Sell
116,166
-125,634
-52% -$5.9M 0.04% 274
2019
Q2 		$11M Buy
241,800
+17,700
+8% +$824K 0.08% 179
2019
Q1 		$10.7M Buy
224,100
+58,800
+36% +$2.93M 0.08% 175
2018
Q4 		$8.59M Buy
165,300
+157,700
+2,075% +$8.47M 0.07% 151
2018
Q3 		$472K Sell
7,600
-3,100
-29% -$184K ﹤0.01% 447
2018
Q2 		$592K Hold
10,700
– – ﹤0.01% 452
2018
Q1 		$677K Hold
10,700
– – ﹤0.01% 424
2017
Q4 		$656K Buy
+10,700
New +$669K ﹤0.01% 424
2017
Q1 		– Sell
-3,500
Closed -$205K – 588
2016
Q4 		$205K Buy
+3,500
New +$191K ﹤0.01% 472
2016
Q3 		– Sell
-3,800
Closed -$279K – 526
2016
Q2 		$279K Sell
3,800
-300
-7% -$21.2K ﹤0.01% 521
2016
Q1 		$262K Sell
4,100
-1,300
-24% -$82K ﹤0.01% 517
2015
Q4 		$371K Hold
5,400
– – ﹤0.01% 462
2015
Q3 		$320K Sell
5,400
-2,010
-27% -$128K ﹤0.01% 513
2015
Q2 		$493K Sell
7,410
-700
-9% -$46.1K ﹤0.01% 394
2015
Q1 		$523K Sell
8,110
-2,652
-25% -$166K ﹤0.01% 390
2014
Q4 		$635K Sell
10,762
-1,509,961
-99% -$85.2M ﹤0.01% 387
2014
Q3 		$77.8M Sell
1,520,723
-301,048
-17% -$15M 0.21% 82
2014
Q2 		$88.4M Sell
1,821,771
-2,322,648
-56% -$114M 0.24% 69
2014
Q1 		$215M Sell
4,144,419
-4,795,438
-54% -$255M 0.56% 38
2013
Q4 		$475M Buy
8,939,857
+570,925
+7% +$29.1M 1.15% 25
2013
Q3 		$387M Buy
8,368,932
+790,999
+10% +$34.7M 1.02% 26
2013
Q2 		$339M Buy
+7,577,933
New +$329M 0.88% 27

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s BMY Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Bristol-Myers Squibb (BMY) stake by 56% in Q1 2026, selling an estimated $31.9M and leaving 432,391 shares worth $26.2M. The position accounts for 0.07% of the portfolio, ranked #148.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BMY in Q2 2013 and has held it in 48 quarters since. The position peaked at $475M in Q4 2013. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 432,391 shares of Bristol-Myers Squibb worth $26.2M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 546,497 Bristol-Myers Squibb shares in Q1 2026, an estimated $31.9M.
  • Bristol-Myers Squibb made up 0.07% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #148 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 48 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Bristol-Myers Squibb position peaked at $475M in Q4 2013.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.